Prominent infection prevention and control (IPC) expert, Dr. Saskia v. Popescu, provides an informative update on some critical topics in her latest ‘Hot Topics in IPC’ report. This discussion spans changes in national health leadership, COVID-19 case surges, tuberculosis (TB) contamination issues related to bone grafts, and more.
One especially significant change she highlights is the recent shift in leadership within the CDC and the NIAID, both crucial public health institutions. These transitions come after a period of unprecedented healthcare crises marked by pandemics and disease outbreaks.
The respective exits of Rochelle Walensky and Anthony Fauci brought Dr. Mandy Cohen and Dr. Jeanne Marrazzo to the frontline as new directors of CDC and NIAID. Dr. Cohen’s rich experience in public health leadership, coupled with her emphasis on trust-building through transparency, performance, and relationship-building, is expected to enhance the United States’ health and pandemic preparedness strategies. Dr. Marrazzo, with her extensive background in infectious disease leadership and research, along with her reputation as an outstanding science communicator and public health advocate, is also heralded for this challenging role. As Dr. Popescu gratefully acknowledges the contributions of the past leadership, she expresses keen interest in observing how these new leaders address ongoing health and scientific issues.
Regarding recent TB outbreaks linked to contaminated bone grafts, with four cases and one death reported already, Dr. Popescu highlights the voluntary recall notice issued by the product manufacturer, Aziyo Biologics. These infections have prompted an ongoing collaboration between CDC and FDA, together with state and local health departments, hospitals, and other health care facilities to ensure patient evaluation and treatment and explore further preventive measures.
Addressing the rising COVID-19 cases, particularly with the emergence of the new EG.5 variant, Dr. Popescu reiterates the recurrent pattern of case surges during summers. Worryingly, CDC data reveals a 12.5% increase in hospitalizations and a 10% rise in deaths over the past week, raising concerns over potentially overwhelmed healthcare infrastructure.
Even as the medical field continues to grapple with these challenges, Dr. Popescu highlights other ongoing issues underscoring the importance of IPC methodologies in the practical field. These include strategies to improve hand hygiene adherence rates, incorporating IPC insights in healthcare construction, and leveraging educational events to foster IPC principles amongst staff.
The rising threat of antimicrobial resistance, fueled in part by bacteria increasingly resistant to modern treatments, is another area highlighted by Dr. Popescu to underscore the urgent need for thorough and expedient IPC measures.
Source: https://www.infectioncontroltoday.com/view/hot-topics-ipc-new-leadership-tuberculosis-covid-19-updates